![Michael Bettess](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Bettess
Presidente presso Currus Biologics Pty Ltd.
Posizioni attive di Michael Bettess
Società | Posizione | Inizio | Fine |
---|---|---|---|
Brandon Capital Partners Pty Ltd.
![]() Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investitore di Private Equity | 01/02/2016 | - |
Cincera Therapeutics Pty Ltd.
![]() Cincera Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Cincera Therapeutics Pty Ltd. is a biotechnology company, which develops molecule drugs. It focuses on the discovery and development of new small molecule drugs aiming to treat difficult-to-treat inflammatory and fibrotic conditions associated with obesity and metabolic disorders, with potential applications in many other disease areas including cancer. The company was founded by Bernard Flynn and Stuart Pitson and is headquartered in Melbourne, Australia. | Direttore/Membro del Consiglio | - | - |
Currus Biologics Pty Ltd.
![]() Currus Biologics Pty Ltd. BiotechnologyHealth Technology Currus Biologics Pty Ltd. is an Australian biotechnology company that develops cell therapies to treat cancers. The company is based in Melbourne, Australia. The CEO of the company is Samantha Cobb. | Presidente | - | - |
Storia della carriera di Michael Bettess
Precedenti posizioni note di Michael Bettess
Società | Posizione | Inizio | Fine |
---|---|---|---|
Trans Tasman Fund Management Pty Ltd.
![]() Trans Tasman Fund Management Pty Ltd. Investment ManagersFinance Trans Tasman Fund Management Pty Ltd (TTCF) is a venture capital firm headquartered in Australia. | Investitore di Private Equity | - | - |
Heart Metabolics Ltd.
![]() Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Direttore/Membro del Consiglio | - | - |
Formazione di Michael Bettess
LaTrobe University | Masters Business Admin |
Statistiche
Distribuzione geografica
Australia | 6 |
Irlanda | 2 |
Posizioni
Director/Board Member | 2 |
Private Equity Investor | 2 |
Chairman | 1 |
Settori
Health Technology | 3 |
Finance | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Brandon Capital Partners Pty Ltd.
![]() Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
Trans Tasman Fund Management Pty Ltd.
![]() Trans Tasman Fund Management Pty Ltd. Investment ManagersFinance Trans Tasman Fund Management Pty Ltd (TTCF) is a venture capital firm headquartered in Australia. | Finance |
Heart Metabolics Ltd.
![]() Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Health Technology |
Cincera Therapeutics Pty Ltd.
![]() Cincera Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Cincera Therapeutics Pty Ltd. is a biotechnology company, which develops molecule drugs. It focuses on the discovery and development of new small molecule drugs aiming to treat difficult-to-treat inflammatory and fibrotic conditions associated with obesity and metabolic disorders, with potential applications in many other disease areas including cancer. The company was founded by Bernard Flynn and Stuart Pitson and is headquartered in Melbourne, Australia. | Commercial Services |
Currus Biologics Pty Ltd.
![]() Currus Biologics Pty Ltd. BiotechnologyHealth Technology Currus Biologics Pty Ltd. is an Australian biotechnology company that develops cell therapies to treat cancers. The company is based in Melbourne, Australia. The CEO of the company is Samantha Cobb. | Health Technology |
- Borsa valori
- Insiders
- Michael Bettess
- Esperienza